KK
IONS icon

KLP Kapitalforvaltning’s Ionis Pharmaceuticals IONS Stock Holding History

KLP Kapitalforvaltning’s Portfolio IONS Stock Details IONS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.93M Buy
37,000
+3,100
+9% +$233K 0.01% 601
2026
Q1 		$2.55M Buy
33,900
+400
+1% +$31.6K 0.01% 624
2025
Q4 		$2.65M Buy
33,500
+2,000
+6% +$151K 0.01% 608
2025
Q3 		$2.06M Hold
31,500
– – 0.01% 691
2025
Q2 		$1.24M Buy
31,500
+4,100
+15% +$134K 0.01% 865
2025
Q1 		$827K Sell
27,400
-1,800
-6% -$58.9K ﹤0.01% 1030
2024
Q4 		$1.02M Buy
+29,200
New +$1.09M ﹤0.01% 987

Other funds holding IONS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

KLP Kapitalforvaltning's IONS Position: Q2 2026 in Review

KLP Kapitalforvaltning increased its Ionis Pharmaceuticals (IONS) stake by 9.1% in Q2 2026, buying an estimated $233K and bringing the position to 37,000 shares worth $2.93M. The position accounts for 0.01% of the portfolio, ranked #601.

KLP Kapitalforvaltning first reported a position in IONS in Q4 2024 and has held it in 7 quarters since. 514 funds tracked by Wall St. Rank hold IONS as of Q2 2026.

  • KLP Kapitalforvaltning held 37,000 shares of Ionis Pharmaceuticals worth $2.93M as of Q2 2026.
  • KLP Kapitalforvaltning bought 3,100 Ionis Pharmaceuticals shares in Q2 2026, an estimated $233K.
  • Ionis Pharmaceuticals made up 0.01% of KLP Kapitalforvaltning's portfolio in Q2 2026, its #601 holding.
  • KLP Kapitalforvaltning first reported a position in Ionis Pharmaceuticals in Q4 2024 and has held it in 7 quarters since.
  • 514 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q2 2026.

Based on KLP Kapitalforvaltning's 13F filing for Q2 2026, filed 12 Aug 2026.